Edge Wealth Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Edge Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$33.21 - $51.27 $16,605 - $25,635	-500 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$20.56 - $63.12 $10,280 - $31,560	500 New	500 $14,000
Q2 2018 Jul 17, 2018	SELL	$6.37 - $14.02 $31,850 - $70,100	-5,000 Closed	0 $0
Q4 2017 Jan 18, 2018	SELL	$3.14 - $4.5 $15,700 - $22,500	-5,000 Reduced 50.0%	5,000 $18,000
Q3 2017 Oct 19, 2017	BUY	$1.69 - $4.33 $16,900 - $43,300	10,000	10,000 $43,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.